406 related articles for article (PubMed ID: 26369382)
61. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
62. Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
Nunthapiwat S; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Gynecol Obstet Invest; 2019; 84(4):326-333. PubMed ID: 30602167
[TBL] [Abstract][Full Text] [Related]
63. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
64. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
65. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
Ong CY; Lee CP; Leung KY; Lau E; Tang MH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
[TBL] [Abstract][Full Text] [Related]
66. Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome.
Räty R; Virtanen A; Koskinen P; Anttila L; Forsström J; Laitinen P; Mörsky P; Tiitinen A; Ekblad U
Hum Reprod; 2002 Feb; 17(2):481-4. PubMed ID: 11821299
[TBL] [Abstract][Full Text] [Related]
67. Endometrial and fetoplacental markers in pregnancies with fetal congenital nephrosis.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):526-30. PubMed ID: 8693927
[TBL] [Abstract][Full Text] [Related]
68. Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case-control study.
Chen Y; Chen Y; Wang X; Chu X; Ning W; Gu L; Li L; Xie Z; Wen C
J Transl Med; 2021 Mar; 19(1):94. PubMed ID: 33653375
[TBL] [Abstract][Full Text] [Related]
69. Prospective prenatal serum screening for Down syndrome in Venezuela.
Alvarez-Nava F; Soto M; Morales-Machín A; Rojas A; Urdaneta K; Cañizález J
Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910
[TBL] [Abstract][Full Text] [Related]
70. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
[TBL] [Abstract][Full Text] [Related]
71. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
72. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
[TBL] [Abstract][Full Text] [Related]
73. Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18.
Chen Y; Ning W; Wang H; Chen Y; Huang J; Wen L; Hu W
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6764-6769. PubMed ID: 33980109
[TBL] [Abstract][Full Text] [Related]
74. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
75. Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects.
Chen Y; Wang X; Chen Y; Ning W; Chen L; Yin Y; Zhang W; Lian J; Wang H
Exp Biol Med (Maywood); 2022 May; 247(10):822-831. PubMed ID: 35238224
[TBL] [Abstract][Full Text] [Related]
76. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
77. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
78. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
79. External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.
Chen Y; Chen Y; Shi Y; Ning W; Wang X; Li L; Zhang H
Med Sci Monit; 2022 Apr; 28():e935573. PubMed ID: 35414638
[TBL] [Abstract][Full Text] [Related]
80. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR
Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
